This systematic review and meta‐analysis of mutation prevalence by tumor location among mCRC patients identified a significant difference in prevalence of both KRAS and BRAF mutations by tumor location, with mutations more frequent among right‐sided colon cancers than left‐sided tumors. This evidence concerns the gene KRAS and colonic neoplasm.